Journal article
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.
- Abstract:
-
PURPOSE: Fluourouracil (FU) is a mainstay of chemotherapy, although toxicities are common. Genetic biomarkers have been used to predict these adverse events, but their utility is uncertain. PATIENTS AND METHODS: We tested candidate polymorphisms identified from a systematic literature search for associations with capecitabine toxicity in 927 patients with colorectal cancer in the Quick and Simple and Reliable trial (QUASAR2). We then performed meta-analysis of QUASAR2 and 16 published studies...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Volume:
- 32
- Issue:
- 10
- Pages:
- 1031-1039
- Publication date:
- 2014-04-01
- DOI:
- EISSN:
-
1527-7755
- ISSN:
-
0732-183X
- Source identifiers:
-
451099
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:451099
- UUID:
-
uuid:37149915-98cb-4193-bf44-38c61bf80608
- Local pid:
- pubs:451099
- Deposit date:
- 2014-05-09
Terms of use
- Copyright date:
- 2014
If you are the owner of this record, you can report an update to it here: Report update to this record